Reactive urotoxic metabolites of ifosfamide

Reactive urotoxic metabolites of ifosfamide, primarily acrolein and chloroacetaldehyde, are byproduct molecules generated during the hepatic activation of the chemotherapy drug ifosfamide (StatPearls, 2023). While ifosfamide mustard provides the intended antineoplastic effect through DNA alkylation, acrolein is highly reactive and concentrates in the urinary bladder, where it causes direct mucosal damage leading to hemorrhagic cystitis (PubChem, CID 7847). Chloroacetaldehyde, another significant metabolite, is associated with systemic toxicities including nephrotoxicity and neurotoxicity, often referred to as ifosfamide-induced encephalopathy (PubMed, PMID 15591231). To mitigate these adverse effects, the drug Mesna (sodium 2-mercaptoethanesulfonate) is co-administered; it contains a thiol group that binds to and neutralizes acrolein in the urine to form a stable, non-toxic thioether (FDA, Mesnex Label). Understanding these metabolites is critical for managing the therapeutic window of ifosfamide and preventing severe treatment-limiting urological and neurological complications. These metabolites represent a unique class of pharmacological targets where the goal is chemical neutralization rather than receptor modulation.

Other names

AcroleinChloroacetaldehyde2-chloroacetaldehydePropenal2-propenalIfosfamide metabolites

Mesna acts as a regional detoxifying agent by reacting chemically with the urotoxic metabolites (specifically acrolein) through its thiol group to form a stable, non-toxic thioether conjugate that is excreted in the urine (FDA, Mesnex Label).